Literature DB >> 15037

Immunochemical and morphological studies of hepatitis B core antigen isolated from the nuclei of hepatocytes.

A Budkowska.   

Abstract

Immunochemical and morphological properties of hepatitis B core antigen (HBc Ag) were studied in intranuclear particles isolated from human liver. Immunochemical integrity of the purified particles was indicated in the production by guinea pigs of antibody to HBc Ag (anti-HBc) that was immunochemically identical to human anti-HBc. The HBc Ag particles were 27-30 nm in diameter, displayed apparent icosahedral symmetry, and consisted of distinct subunits. The susceptibility of HBc Ag particles to proteolytic and glycolytic enzymes indicated the presence of proteins and glycoproteins. The structural integrity of core particles depended on disulfide, hydrophobic, and hydrogen bonds, and immunological activity relied on intact sulfhydryl groups. Agents active against lipids did not affect immunological reactivity or core structure, as seen by electron microscopy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 15037     DOI: 10.1093/infdis/135.3.463

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  4 in total

Review 1.  The nature of the hepatitis B virus and its mode of replication.

Authors:  C R Howard
Journal:  Springer Semin Immunopathol       Date:  1981-04

Review 2.  The hepatitis B virus and its DNA polymerase: the prototype three-D virus.

Authors:  S Z Hirschman
Journal:  Mol Cell Biochem       Date:  1979-07-15       Impact factor: 3.396

3.  Stability of the recombinant hepatitis B core antigen.

Authors:  N Nath; K Hickman; S Nowlan; D Shah; J Phillips; S Babler
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

4.  Membranous glomerulopathy associated with hepatitis B core antigen immune complexes in children.

Authors:  J Slusarczyk; T Michalak; T Nazarewicz-de Mezer; K Krawczyński; A Nowosławski
Journal:  Am J Pathol       Date:  1980-01       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.